Zoetis Inc. ZTS
82.21 USD -3.36 (-3.93%)
As ofNov 19, 2026, 11:07 AM EST
82.00 Day range 84.87
69.10 52-week range 131.10
- YTD
- -34.66%
- 1 year
- -29.79%
News
benzinga.com Zoetis Says USDA Licenses Poulvac Procerta HVT-ND-ILT, Vector Vaccine For Chickens 3-in-1 vector vaccine expands disease-protection options for chickens, backed by Zoetis’ comprehensive vaccine portfolio and specialized expertise What it protects against: Poulvac® Procerta®…
businesswire.com Zoetis Receives USDA License for Poulvac® Procerta® HVT-ND-ILT Vaccine for Chickens PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) today announced that the U.S. Department of Agriculture (USDA) has licensed Poulvac® Procerta® HVT-ND-ILT, a vector…
benzinga.com Rep. Byron Donalds Sells Netflix Stock for Loss: Here’s What He’s Buying Instead Congressman Byron Donalds is set to leave congress as the newly elected governor of Florida. Here's his recent stock trades.
seekingalpha.com Zoetis Inc. (ZTS) Presents at Jefferies Global Healthcare Conference 2026 Transcript Zoetis Inc. (ZTS) Presents at Jefferies Global Healthcare Conference 2026 Transcript
defenseworld.net Eurizon Capital SGR S.p.A. Sells 75,462 Shares of Zoetis Inc. $ZTS Eurizon Capital SGR S.p.A. lowered its position in shares of Zoetis Inc. (NYSE: ZTS) by 48.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange…
defenseworld.net Zoetis Inc. $ZTS Shares Sold by Commonwealth Equity Services LLC Commonwealth Equity Services LLC lowered its stake in Zoetis Inc. (NYSE: ZTS) by 24.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission…
zacks.com Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief ZTS' Cytopoint Plus secures a USDA license, offering dogs with allergic dermatitis 75 days of itch relief and a longer interval between injections.
seekingalpha.com SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For November 2026 The 4-Factor Dividend Growth Strategy targets quality and total return, outperforming SCHD with a 14.98% average return versus SCHD's 14.31%. I select stocks based on free cash flow to debt, 5-year…
benzinga.com Republican Senator Who Won Reelection Is Selling Magnificent Seven Stocks: Here Are the Trades Sen. Shelley Moore Capito, who won reelection, sold shares of Apple, Meta and Microsoft weeks before the midterms. Here are the trades.
benzinga.com Zoetis Lifts Annual Outlook While Braces For Cautious Pet Economy Zoetis beats Q3 earnings and revenue estimates, lifts full-year 2026 guidance, and balances pet care affordability pressures with steady livestock gains.
benzinga.com Zoetis Q3 2026 Earnings Call Transcript Zoetis (NYSE:ZTS) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com Zoetis Raises FY2026 Adj EPS Guidance from $6.15-$6.25 to $6.25-$6.35 vs $6.28 Est; Raises FY2026 Sales Guidance from $9.120B-$9.320B to $9.220B-$9.320B vs $9.326B Est Zoetis (NYSE:ZTS) raises FY2026 Adj EPS guidance from $6.15-$6.25 to $6.25-$6.35 vs $6.28 analyst estimate. Raises FY2026 sales outlook from $9.120 billion-$9.320 billion to $9.220 billion-$9.320…
benzinga.com Zoetis Q3 Adj. EPS $1.75 Beats $1.51 Estimate, Sales $2.391B Beat $2.304B Estimate Zoetis (NYSE:ZTS) reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.51 by 15.89 percent. This is a 2.94 percent increase over earnings of $1.70 per share…
benzinga.com Morgan Stanley Maintains Overweight on Zoetis, Lowers Price Target to $82 Morgan Stanley analyst Erin Wright maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $85 to $82.
benzinga.com UBS Maintains Neutral on Zoetis, Raises Price Target to $85 UBS analyst Andrea Alfonso maintains Zoetis (NYSE:ZTS) with a Neutral and raises the price target from $80 to $85.
benzinga.com This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Analysts downgraded Werner, Zoetis, Apple, Heartland Express and Elanco, cutting ratings to Neutral/Hold and lowering price targets.benzinga.com Jefferies Downgrades Zoetis to Hold, Lowers Price Target to $83 Jefferies analyst Keith Devas downgrades Zoetis (NYSE:ZTS) from Buy to Hold and lowers the price target from $103 to $83.
finance.yahoo.com Quantinuum Inc. (QNT) Quantinuum’s latest update showed strong bookings and revenue growth, supported by Oracle, RIKEN, and SoftBank collaborations. The company also raised 2026 revenue guidance, but remains deeply ...
finance.yahoo.com SK hynix Inc. (SKHY) SK hynix is gaining support from Nvidia’s stronger outlook and expanded memory commitments. The company enters this period with record third-quarter profitability, long-term capacity agreements, and…
finance.sina.com.cn 硕腾收涨2.5%,成交额3.96亿美元 11月19日,硕腾(ZTS)收涨2.5%,报85.57美元,成交额3.96亿美元,市值347.68亿美元。 公司最新财报显示,季度营收23.91亿美元;净利润5.91亿美元。 公司简介…
cryptobriefing.com Zoetis wins USDA license for 3-in-1 chicken vaccine Zoetis regulatory action: the USDA has licensed Poulvac Procerta HVT-ND-ILT, a 3-in-1 vector vaccine for chickens, from ...
fidelity.co.uk Zoetis Inc Class A (ZTS) Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry,…
finance.yahoo.com ETFs Are Net Sellers of Zoetis (ZTS) on Monday Every ETF and guru trade in ZTS is tracked on the ZTS guru trades page. The largest sellers by dollar value were DUHP ($26.5 million), XLV ($0.2 million) and SPHQ ($0.0 million). In all, 29 ETFs…
finance.yahoo.com Zoetis (ZTS) Stock Still Looks Cheap Following Fresh Dog Allergy Treatment News Zoetis has seen its share price fall a long way over the past few years, even as it continues to lean on its earnings power in animal health, so the obvious question now is whether the current ...
finance.yahoo.com iShares Biotechnology ETF (IBB) Buys $16.2 Million More Gilead on Nov. 16 iShares Biotechnology ETF ( IBB) recorded net buying of $176.7 million in Monday's session, with gross ETF activity of the ...
finance.yahoo.com Zoetis Receives USDA License for Poulvac® Procerta® HVT-ND-ILT Vaccine for Chickens Zoetis Inc. (NYSE: ZTS) today announced that the U.S. Department of Agriculture (USDA) has licensed Poulvac® Procerta® HVT-ND ...
finance.yahoo.com How Triple Poultry Vaccine Approval At Zoetis Stock Has Changed Its Investment Story ILT, a vector vaccine for chickens that targets Marek’s disease, Newcastle disease and infectious laryngotracheitis in a ...
marketscreener.com Zoetis Receives USDA License for 3-Disease Chicken Vaccine Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by ...
theglobeandmail.com Barclays Remains a Hold on Zoetis (ZTS) Barclays analyst Glen Santangelo maintained a Hold rating on Zoetis today and set a price target of $85.00. According to TipRanks, Santangelo is a 4-star analyst with an average return of 4.3% and a…
marketwatch.com Zoetis Inc. stock outperforms competitors on strong trading day Zoetis Inc. closed 35.41% below its 52-week high of $132.49, which the company achieved on February 12th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with ...
ad-hoc-news.de Zoetis stock gets USDA license for three-disease poultry vaccine Zoetis stock gets a new poultry-health catalyst after U.S. regulators license a three-disease vaccine. The product targets ...
marketscreener.com Zoetis Inc. Receives USDA License for Poulvac Procerta HVT-ND-ILT Vaccine for Chickens Zoetis Inc. received a license from the U.S. Department of Agriculture for Poulvac Procerta HVT-ND-ILT, a vector vaccine for ...
msn.com Rep. Byron Donalds sells Netflix stock for loss: Here’s what he’s buying instead Rep. Byron Donalds (R-Fla.) is one of the many members of Congress who have their stock trades regularly tracked by the ...
